Primary Myelofibrosis Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +155 more
2022-04-06
Apr 6, 2022
C
Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
2022-04-05
Apr 5, 2022
C
Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +92 more
2022-04-04
Apr 4, 2022
N
Recruiting
  • Primary Myelofibrosis
  • +4 more
  • ruxolitinib tablets or oral pediatric formulation, panobinostat capsules
  • ruxolitinib tablets or oral pediatric formulation
  • Darlinghurst, New South Wales, Australia
  • +96 more
2022-03-29
Mar 29, 2022
C
Recruiting
  • Myelofibrosis
  • +13 more
  • Phoenix, Arizona
  • +54 more
2022-03-04
Mar 4, 2022
C
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
U
Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-25
Feb 25, 2022
O
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +58 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2022-02-16
Feb 16, 2022
S
Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +166 more
2022-01-27
Jan 27, 2022
I
Recruiting
  • Thrombocythemia, Essential
  • Primary Myelofibrosis
  • Hong Kong, Hong Kong
    Queen Mary Hospital
2022-01-24
Jan 24, 2022
M
Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
2022-01-07
Jan 7, 2022
M
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-04
Jan 4, 2022
H
Completed
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
2021-12-07
Dec 7, 2021
F
Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-14
Dec 14, 2021
F
Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-13
Dec 13, 2021
N
Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Chicago, Illinois
  • +13 more
2021-11-30
Nov 30, 2021